The SARS-CoV-2 virus that causes COVID-19 has killed 6 million people worldwide since 2019.

Researchers now have discovered a monoclonal antibody that potentially acts as a potent universal coronavirus therapy against the COVID-19 virus and all its variants of concern, including delta and omicron. It also shows effectiveness against the deadly coronaviruses SARS, the Severe Acute Respiratory Syndrome that emerged in China in 2002, and MERS, the Middle East Respiratory Syndrome that appeared in Saudi Arabia in 2012. It even shows effectiveness against several common cold coronaviruses.

This universal activity results from the monoclonal antibody targeting a region of the viral spike protein that is highly conserved among beta-coronaviruses, yet i...

Whether it’s photovoltaics or fusion, sooner or later, human civilization must turn to renewable energies. This is deemed inevitable, considering the ever-growing energy demands of humanity and the finite nature of fossil fuels. Much research has been pursued in order to develop alternative sources of energy, most of which use electricity as the main energy carrier...

Researchers show which molecular processes promote secondary diseases in obesity. Obesity and overweight are among the biggest health challenges of the 21st century, according to the World Health Organization (WHO). Almost 60 percent of Germans are considered overweight, while 25 percent are obese. Moreover, being overweight often triggers severe secondary diseases such as diabetes, arteriosclerosis, or heart attacks.

Immunological processes determine the course of this disease. As part of a new study, a group of LMU researchers led by Dr...